Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 14/20 | 0.75 |
| ▸ | LPAR2 | Q9HBW0 | 8/20 | 0.75 |
| ▸ | LPAR1 | Q92633 | 6/20 | 0.75 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.50 |
| ▸ | P2RY10 | O00398 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL146276 | 1.00 | LPAR3 (0.75) | LPAR3LPAR2LPAR1CYP3A4LPAR5 | |
| SCHEMBL11743002 | 1.00 | LPAR3 (0.75) | LPAR3LPAR2LPAR1CYP3A4LPAR5 | |
| SCHEMBL3813447 | 1.00 | LPAR3 (0.75) | LPAR3LPAR2LPAR1CYP3A4LPAR5 | |
| SCHEMBL6158233 | 1.00 | LPAR3 (0.75) | LPAR3LPAR2LPAR1CYP3A4LPAR5 | |
| SCHEMBL9437012 | 1.00 | LPAR3 (0.75) | LPAR3LPAR2LPAR1CYP3A4LPAR5 | |
| SCHEMBL11742600 | 1.00 | LPAR3 (0.75) | LPAR3LPAR2LPAR1CYP3A4LPAR5 | |
| SCHEMBL3463036 | 1.00 | LPAR3 (0.75) | LPAR3LPAR2LPAR1CYP3A4LPAR5 | |
| SCHEMBL21437002 | 1.00 | LPAR3 (0.75) | LPAR3LPAR2LPAR1CYP3A4LPAR5 | |
| SCHEMBL22974810 | 1.00 | LPAR3 (0.75) | LPAR3LPAR2LPAR1CYP3A4LPAR5 | |
| SCHEMBL8507194 | 1.00 | LPAR3 (0.75) | LPAR3LPAR2LPAR1CYP3A4LPAR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119318707-A | Methods of reducing side effects of administration of phosphodiesterase-4 inhibitors | 阿尔库缇斯生物疗法股份有限公司 | 2025-01-17 | — | — | CN | disclosed |
| CN-119097625-A | Method and formulation for improving skin permeation lag time of roflumilast | 阿尔库缇斯生物疗法股份有限公司 | 2024-12-10 | — | — | CN | disclosed |
| CN-118141762-B | Foam-type pharmaceutical agent and foam composition for topical application | 北京罗诺强施医药技术研发中心有限公司 | 2024-07-12 | — | — | CN | disclosed |
| CN-118141762-A | Foam-type pharmaceutical agent and foam composition for topical application | 北京罗诺强施医药技术研发中心有限公司 | 2024-06-07 | — | — | CN | disclosed |
| CN-118085488-A | Preparation method of self-synthesized phosphate nucleating agent reinforced polypropylene composite pipe | 福州大学 | 2024-05-28 | — | — | CN | disclosed |
| CN-113831575-A | Use of twin-tailed long chain anionic surfactants in aqueous polyurethane dispersions | 赢创运营有限公司 | 2021-12-24 | — | — | CN | disclosed |
| US-8017562-B2 | Gelled hydrocarbons for oilfield processes, phosphate ester compounds useful in gellation of hydrocarbons and methods for production and use thereof | BRINE-ADD FLUIDS LTD. (CA) | 2011-09-13 | — | — | US | disclosed |
| US-7972996-B2 | Gelled hydrocarbons for oilfield processes, phosphate ester compounds useful in gellation of hydrocarbons and methods for production and use thereof | Brine-Add Fluids Ltd (CA) | 2011-07-05 | — | — | US | disclosed |
| US-7947632-B2 | Gelled hydrocarbons for oilfield processes, phosphate ester compounds useful in gellation of hydrocarbons and methods for production and use thereof | BRINE-ADD FLUIDS LTD. (CA) | 2011-05-24 | — | — | US | disclosed |
| US-20110100633-A1 | GELLED HYDROCARBONS FOR OILFIELD PROCESSES, PHOSPHATE ESTER COMPOUNDS USEFUL IN GELLATION OF HYDROCARBONS AND METHODS FOR PRODUCTION AND USE THEREOF | BRINE-ADD FLUIDS LTD. (CA) | 2011-05-05 | — | — | US | disclosed |
| US-20110046408-A1 | GELLED HYDROCARBONS FOR OILFIELD PROCESSES, PHOSPHATE ESTER COMPOUNDS USEFUL IN GELLATION OF HYDROCARBONS AND METHODS FOR PRODUCTION AND USE THEREOF | BRINE-ADD FLUIDS LTD. (CA) | 2011-02-24 | — | — | US | disclosed |
| US-20090203556-A1 | GELLED HYDROCARBONS FOR OILFIELD PROCESSES, PHOSPHATE ESTER COMPOUNDS USEFUL IN GELLATION OF HYDROCARBONS AND METHODS FOR PRODUCTION AND USE THEREOF | BRINE-ADD FLUIDS LTD. (CA) | 2009-08-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110046408-A1 | GELLED HYDROCARBONS FOR OILFIELD PROCESSES, PHOSPHATE ESTER COMPOUNDS USEFUL IN GELLATION OF HYDROCARBONS AND METHODS FOR PRODUCTION AND USE THEREOF | DAGLA, PHOSPHO1, DGKG | LPAR3 1230/4885LPAR2 1651/4885LPAR1 1361/4885 |
| US-20090203556-A1 | GELLED HYDROCARBONS FOR OILFIELD PROCESSES, PHOSPHATE ESTER COMPOUNDS USEFUL IN GELLATION OF HYDROCARBONS AND METHODS FOR PRODUCTION AND USE THEREOF | DAGLA, PHOSPHO1, DGKG | LPAR3 1230/4885LPAR2 1651/4885LPAR1 1361/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.